// App-Quantinova.ai

2593 : Cyclophosphamide for the Treatment of Skin Fibrosis in Systemic Sclerosis: A Systematic Review

Researchers

Presenter

  • Marie Hudson

Principal Investigators

  • Catherine Ivory

  • Melissa Demery-Varin

Medical Centers

  • Jewish General Hospital, Lady Davis Institute for Medical Research, McGill University, Montreal, QC, Canada

  • The Ottawa Hospital, Ottawa

  • University of Ottawa, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Genetic Disorder

  • Autoimmune (AI)

Disease

  • Scleroderma

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Multinational

  • Prospective

  • Controlled

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved